13D/13G Filings - Growth Equity Opportunities V LLC

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2024-03-18
9:13 pm
Purchase
2024-03-14 13D Regulus Therapeutics Inc.
RGLS
Growth Equity Opportunities V LLC 6,533,102
9.990%
4,587,523increase
(+235.79%)
Filing
History
2023-05-12
1:57 pm
Purchase
2023-04-13 13D Regulus Therapeutics Inc.
RGLS
Growth Equity Opportunities V LLC 1,945,579
9.990%
487,327increase
(+33.42%)
Filing
History
2023-03-09
4:10 pm
Sale
2023-03-09 13D MEI Pharma, Inc.
MEIP
Growth Equity Opportunities V LLC 1
5.000%
-498,160decrease
(-100.00%)
Filing
History
2022-07-22
4:06 pm
Sale
2022-07-11 13D CTI BioPharma Corp.
CTIC
Growth Equity Opportunities V LLC 0
0.000%
-9,613,101decrease
(Position Closed)
Filing
History
2022-06-17
5:10 pm
Purchase
2022-06-07 13D CTI BioPharma Corp.
CTIC
Growth Equity Opportunities V LLC 9,613,101
8.800%
2,228,285increase
(+30.17%)
Filing
History
2021-12-09
2:58 pm
Purchase
2021-11-30 13D Regulus Therapeutics Inc.
RGLS
Growth Equity Opportunities V LLC 1,458,252
9.990%
1,253,007increase
(+610.49%)
Filing
History
2021-11-19
06:44 am
Sale
2021-11-16 13D Trillium Therapeutics Inc.
TRIL
Growth Equity Opportunities V LLC 0
0.000%
-6,586,363decrease
(Position Closed)
Filing
History
2021-08-31
6:43 pm
Unchanged
2021-08-20 13D Trillium Therapeutics Inc.
TRIL
Growth Equity Opportunities V LLC 6,586,363
6.300%
0
(Unchanged)
Filing
History